Phenotypic features of innate and adaptive immunity in patients with chronic hepatitis C and end-stage renal disease

被引:6
|
作者
Barbosa, Katia V. B. D. [1 ]
Teixeira, Rosangela [2 ]
Bassetti-Soares, Eric [2 ]
Meirelles de Souza, Aecio F. [1 ]
Penido, Joao Milton M. O. [3 ]
Teixeira-Carvalho, Andrea [4 ]
Martins-Filho, Olindo A. [4 ]
机构
[1] Univ Fed Juiz de Fora, Univ Hosp, Serv Gastroenterol, Juiz De Fora, MG, Brazil
[2] Univ Fed Minas Gerais, Hosp Clin, Inst Alfa Gatroenterol, Dept Clin Med, Belo Horizonte, MG, Brazil
[3] Nucleo Nefrol Belo Horizonte, Belo Horizonte, MG, Brazil
[4] Fundacao Oswaldo Cruz, CPqRR, Belo Horizonte, MG, Brazil
关键词
chronic hepatitis C; end-stage renal disease; flow cytometry; immune response; NATURAL-KILLER-CELLS; CHEMOKINE RECEPTORS; CLINICAL-RELEVANCE; T-CELLS; VIRUS; LIVER; INFECTION; IMMUNOPATHOGENESIS; SUBPOPULATIONS; LYMPHOCYTES;
D O I
10.1111/liv.12204
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: The knowledge of the immunological profile of patients with chronic hepatitis C (CHC) and end-stage renal disease (ESRD) on haemodialysis (HD) is still limited. Aims: This study investigated the immune response profile in HCV patients with concomitant ESRD focusing on the influence of the renal disease on the phenotypic profile of peripheral blood lymphocytes. Methods: Immunophenotypic features of peripheral blood leucocytes were assessed by flow cytometry in two distinct groups: HCV patients with ESRD (CHC+ESRD, n = 16) and HCV patients with normal renal function (CHC, n = 20). Two control groups that were included were as follows: HCV negative blood donors (BD, n = 15) and HCV negative patients with ESRD (ESRD, n = 19). Results: Higher frequency of macrophage-like and pro-inflammatory monocytes along with enhanced frequency of CD3(-)CD16(-)CD56(+), mainly CD56(DIM) NK-cells, were the hallmark of CHC+ESRD patients. Lower frequency of B cells with significant decreased of B1 and CD23(+) B-cells were associated with ESRD, regardless the HCV infection. Although higher rates of activated CD4(+) and CD8(+) T cells were observed in the CHC and CHC+ESRD groups, the chemotaxis of T-cell subsets, based on their chemokine receptor expression, was affected by ESRD. Conclusions: Chronic hepatitis C patients with ESRD on HD exhibit distinctive phenotypic profile of circulating leucocytes. It may be implicated in the natural history of HCV infection in this particular group of patients and warrants further investigation.
引用
收藏
页码:1349 / 1356
页数:8
相关论文
共 50 条
  • [21] Sofosbuvir and Ribavirin is safe and effective therapy in chronic hepatitis C patients with end-stage renal disease on haemodialysis
    Nayak, Sumanlata
    Sharma, Manoj
    Mathur, Rajendra P.
    Varma, Prem Prakash
    Gupta, Ekta
    Choudhary, Ashok
    Jamwal, Kapil D.
    Maiwall, Rakhi
    Kumar, Guresh
    Bhardwaj, Ankit
    Sarin, Shiv K.
    HEPATOLOGY, 2016, 64 : 425A - 425A
  • [22] Timing of Treatment for Chronic Hepatitis C Infection in Patients with End-Stage Renal Disease Awaiting Transplantation.
    Eckman, M.
    Woodle, E.
    Thakar, C.
    Paterno, F.
    Sherman, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 780 - 780
  • [23] Sofosbuvir and Velpatasvir Regimen Outcome for Chronic Hepatitis C Patients With End-Stage Renal Disease Undergoing Hemodialysis
    Shahid, Salman
    Asghar, Shoaib
    Mahmood, Tayyab
    Fatima, Mishal
    Rasheed, Ali
    Asghar, Sohaib
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [24] Efficacy and tolerance of interferon-α in the treatment of chronic Hepatitis C in end-stage renal disease patients on hemodialysis
    Rocha, CM
    Perez, RM
    Ferreira, AP
    Carvalho-Filho, RJ
    Pace, FH
    Silva, IS
    Pestana, JOM
    Lanzoni, VP
    Silva, AE
    Ferraz, MLG
    LIVER INTERNATIONAL, 2006, 26 (03) : 305 - 310
  • [25] Hepatitis C virus infection and its treatment in patients with end-stage renal disease
    Rostaing, Lionel
    Alric, Laurent
    Izopet, Jacques
    Kamar, Nassim
    SEMINARS IN DIALYSIS, 2014, 27 (05) : 451 - +
  • [26] C HEPATITIS INFECTION AGGRAVATES END-STAGE RENAL DISEASE RISK IN DIABETES PATIENTS
    Hwang, Jyh-Chang
    Jiang, Ming-Yan
    Lu, Yi-Hua
    Weng, Shih-Feng
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [27] Is percutaneous liver biopsy safe in patients with hepatitis C and end-stage renal disease?
    Eric R Kallwitz
    Scott J Cotler
    Nature Clinical Practice Gastroenterology & Hepatology, 2008, 5 : 420 - 421
  • [28] Is percutaneous liver biopsy safe in patients with hepatitis C and end-stage renal disease?
    Kallwitz, Eric R.
    Cotler, Scott J.
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2008, 5 (08): : 420 - 421
  • [29] Pathophysiology and Treatment of Hepatitis B and C Infections in Patients With End-Stage Renal Disease
    Soi, Vivek
    Daifi, Chantale
    Yee, Jerry
    Adams, Elizabeth
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2019, 26 (01) : 41 - 50
  • [30] Clinical presentation of chronic hepatitis C in patients with end-stage renal disease and on hemodialysis versus those with normal renal function
    Hu, KQ
    Lee, SM
    Hu, SX
    Xia, VW
    Hillebrand, DJ
    Kyulo, NL
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : 2010 - 2018